标题
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
作者
关键词
-
出版物
Science Translational Medicine
Volume 4, Issue 127, Pages 127rv3-127rv3
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2012-03-29
DOI
10.1126/scitranslmed.3003180
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applying What We Know to Accelerate Cancer Prevention
- (2012) G. A. Colditz et al. Science Translational Medicine
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- MRI of the prostate: Clinical relevance and emerging applications
- (2011) Yousef Mazaheri et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
- (2011) John R Prensner et al. NATURE BIOTECHNOLOGY
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Predictive biomarkers: a paradigm shift towards personalized cancer medicine
- (2011) Nicholas B. La Thangue et al. Nature Reviews Clinical Oncology
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer
- (2011) G. Tavoosidana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions
- (2011) David Bonekamp et al. RADIOGRAPHICS
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling
- (2010) Ayman S. Moussa et al. BJU INTERNATIONAL
- American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
- (2010) A. M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
- (2010) Monique J. Roobol et al. EUROPEAN UROLOGY
- Exosomes as Biomarker Treasure Chests for Prostate Cancer
- (2010) Diederick Duijvesz et al. EUROPEAN UROLOGY
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- Overdiagnosis in Cancer
- (2010) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Breast cancer assessment tools and optimizing adjuvant therapy
- (2010) Catherine Oakman et al. Nature Reviews Clinical Oncology
- Comparative Effectiveness and Health Care Spending — Implications for Reform
- (2010) Milton C. Weinstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of genome-wide and replication association studies on prostate cancer
- (2010) Hong Liu et al. PROSTATE
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
- (2009) Tineke Wolters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
- (2009) J Nilsson et al. BRITISH JOURNAL OF CANCER
- Rational approach to implementation of prostate cancer antigen 3 into clinical care
- (2009) Rou Wang et al. CANCER
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
- (2009) Anuradha Gopalan et al. CANCER RESEARCH
- Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
- (2009) L. Zhao et al. CANCER RESEARCH
- Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
- (2009) G. Attard et al. CANCER RESEARCH
- Oncogenic gene fusions in epithelial carcinomas
- (2009) John R Prensner et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction
- (2009) Akash Nanda JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rethinking Screening for Breast Cancer and Prostate Cancer
- (2009) Laura Esserman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers
- (2009) C. Nicole Rosenzweig et al. JOURNAL OF UROLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- The use of PCA3 in the diagnosis of prostate cancer
- (2009) Daphne Hessels et al. Nature Reviews Urology
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test
- (2009) Pamela A. Shaw et al. Statistics in Biopharmaceutical Research
- Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research
- (2008) R. O. Barnes et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
- (2008) M. S. Lucia et al. Cancer Prevention Research
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
- (2008) B. Laxman et al. CANCER RESEARCH
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
- (2008) G. Sardana et al. CLINICAL CHEMISTRY
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population
- (2008) David Ulmert et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomic Analysis of Conditioned Media from the PC3, LNCaP, and 22Rv1 Prostate Cancer Cell Lines: Discovery and Validation of Candidate Prostate Cancer Biomarkers
- (2008) Girish Sardana et al. JOURNAL OF PROTEOME RESEARCH
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
- The cancer biomarker problem
- (2008) Charles L. Sawyers NATURE
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
- (2008) Martin G. Sanda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Prostate Cancer in 2007
- (2007) Fritz H. Schröder et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer
- (2007) Axel Heidenreich et al. EUROPEAN UROLOGY
- The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy
- (2007) Danil V. Makarov et al. JOURNAL OF UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started